| Autor: |
Sideris SK; Department of Cardiology, General Hospital of Karditsa, Greece. skevos1@otenet.gr, Bonios MJ, Eftihiadis EE, Melexopoulou CA, Mousiama TA, Diplaris KT, Kogias JS |
| Jazyk: |
angličtina |
| Zdroj: |
Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese [Hellenic J Cardiol] 2005 May-Jun; Vol. 46 (3), pp. 242-6. |
| Abstrakt: |
Heparin-induced thrombocytopenia represents a serious side effect of heparin therapy. Immune-mediated platelet activation results in thrombocytopenia, endothelial thrombin release and development of thrombosis, mainly venous. We report the case of a man with a history of coronary artery disease and recent stent implantation. This patient developed severe heparin-induced thrombocytopenia type II after low molecular weight heparin administration because of unstable angina which occurred two months after stent implantation. The patient was treated with a new anticoagulant regimen, fondaparinux sodium. There were no complications and platelet counts were restored to normal levels. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
